Literature DB >> 10792796

Cutis marmorata telangiectatica congenita: clinical findings in 85 patients.

D B Amitai1, S Fichman, P Merlob, Y Morad, M Lapidoth, A Metzker.   

Abstract

Cutis marmorata telangiectatica congenita (CMTC) is an uncommon, sporadic, congenital cutaneous condition presenting with persistent cutis marmorata, telangiectasia, phlebectasia and possible ulceration of the involved skin, skin atrophy, and undergrowth of the involved extremity. To further the current understanding of this disorder, we analyzed the clinical features of a large series of patients with CMTC. The files of 85 patients with CMTC who were examined in our center over the last 20 years were reviewed. The data recorded included patient sex, age at onset, nature and distribution of the lesions, associated abnormalities, and course of disease. CMTC was characterized by early recognition of the lesions (94% at birth) and equal sex distribution. The lesion was unilateral in 65% of patients and most commonly involved the limbs (69%). Additional capillary lesions, noted in 20% of patients, may well have been an extension of the CMTC itself. Associated anomalies were found in 18.8% of patients. Almost half of the patients showed a definite improvement in the reticular vascular pattern on follow-up. No familial cases of CMTC were noted. CMTC is more prevalent than previously recognized, affects both sexes equally, and has a mostly localized distribution; additional vascular lesions are associated with the disorder, but other anomalies occur less often. Prognosis is generally good.

Entities:  

Mesh:

Year:  2000        PMID: 10792796     DOI: 10.1046/j.1525-1470.2000.01723.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  6 in total

1.  Fetal plasma testosterone correlates positively with cortisol.

Authors:  R Gitau; D Adams; N M Fisk; V Glover
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

2.  Cutis marmorata telangiectatica congenita with gangrenous ulceration and hypovolaemic shock.

Authors:  I-Jan Hu; Ming-Ting Chen; Hao-Chih Tai; Po-Nien Tsao; Hung-Chieh Chou; Wu-Shiun Hsieh
Journal:  Eur J Pediatr       Date:  2005-04-06       Impact factor: 3.183

3.  Cutis marmorata telangiectatica congenita: a mimicker of a common disorder.

Authors:  Rebecca Levy; Joseph M Lam
Journal:  CMAJ       Date:  2011-01-10       Impact factor: 8.262

4.  ARL6IP6, a susceptibility locus for ischemic stroke, is mutated in a patient with syndromic Cutis Marmorata Telangiectatica Congenita.

Authors:  Iman S Abumansour; Hadia Hijazi; Anas Alazmi; Fatma Alzahrani; Fahad A Bashiri; Hamdy Hassan; Mohammed Alhaddab; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2015-05-10       Impact factor: 4.132

5.  Cutis marmorata telangiectatica congenita.

Authors:  Vinoth N Ponnurangam; Venkataraman Paramasivam
Journal:  Indian Dermatol Online J       Date:  2014-01

6.  Cutis marmorata telangiectatica congenita in a preterm newborn - Case report and literature review.

Authors:  A Matic; S Pricic; Milan Matic; G Velisavljev Filipovic; A Ristivojevic
Journal:  Iran Red Crescent Med J       Date:  2012-09-30       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.